Arca
Skip to content
Tools
Tools

HTR2B: 5-hydroxytryptamine receptor 2B

G protein-coupled receptor for 5-hydroxytryptamine (serotonin).

  • Drugs that act on it: 4
  • Approved: 2
  • In phases 1 to 3: 2
  • Sponsors: 3

Who is on it, and how far along

Every drug ChEMBL records acting on HTR2B, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 4

Approved2

  • Methylergonovine
  • Methysergide

Phase 30

    Phase 22

    • PRX-08066 free base
    • Vabicaserin

    Phase 10

      Sponsors

      Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

      • Wyeth is now a wholly owned subsidiary of Pfizer125%

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 3 of 4 act as: Serotonin 2b (5-HT2b) receptor antagonist; the rest name their own mechanism.
      MethylergonovineApprovedEdison TherapeuticsSmall moleculePartial agonistSerotonin 2b (5-HT2b) receptor partial agonist3
      MethysergideApprovedNovartis PharmaceuticalsSmall moleculeAntagonist0
      PRX-08066 free basePhase 2—Small moleculeAntagonist0
      VabicaserinPhase 2Wyeth is now a wholly owned subsidiary of PfizerSmall moleculeAntagonist0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 3 in all, from ClinicalTrials.gov.

      Diseases most associated with it

      Open Targets association score, 0 to 1; all associations
      Post operative nausea and vomiting
      0.48
      Psychotic disorder
      0.48
      Obesity disorder
      0.47
      Spontaneous abortion
      0.37
      Drooling
      0.26
      Bardet-Biedl syndrome
      0.11

      Genes and related targets

      Complexes and families that share a gene with this target
      Genes
      HTR2B

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1833, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P41595, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

      Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.